Stock Report

Download full stock data and analysis for free Last Updated: 04-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Deep Medicine Acquisition Corp (DMAQ) Key Ratios

Stock Card factsheet share-fund-plan-icon

$2.98

up-down-arrow $-5.41 (-64.48%)

As on 31-Jan-2024 19:59EDT

Market cap

info icon

$13 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

22

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- -- -49.31 -- --
Net Profit -33.15 -162.35 92.47 -- --
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-23Mar-22
EBIT-Margin info -----3,129.50----
Net Margin info -----1,721.63----
Return on equity info -------0.63-0.58
Return on Capital info -------0.62-0.57
Return on Assets info -----11.85-0.58-0.55
Debt to Equity (x) info ----0.000.730.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
-0.62
-0.57
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
-0.63
-0.58
--
--
Peer Median
24.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-11.85

Lower than Peers by 9.28

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-11.85
-0.58
-0.55
--
--
Peer Median
-2.58
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-3,129.50

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-3,129.50
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-1,721.63

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-1,721.63
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-49.31

Lower than Peers by 107.10

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-49.31
25.77
-482.94
--
--
Peer Median
57.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

92.47

Higher than Peers by 121.15

Year on year growth in profit after tax

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
92.47
-11.74
--
--
--
Peer Median
-28.68
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
0.73
0.00
-53.22
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
0.73
0.00
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.86

Higher than Peers by 1.71

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
1.86
3.50
240.27
13.12
--
Peer Median
0.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.86

Higher than Peers by 1.72

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
1.86
--
--
--
--
Peer Median
0.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-7.15

Lower than Peers by 8.81

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-7.15
--
-55.85
--
--
Peer Median
1.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.01

--

Sales / Average Total Assets

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
0.01
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Book Value

22.01

Higher than Peers by 18.62

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
22.01
--
--
--
--
Peer Median
3.39
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-8.23

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
-8.23
1.98
315.78
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

13

Higher than Peers by 4

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Deep Medicine Acquisition Corp (DMAQ)
13
--
--
--
--
Peer Median
9
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...